Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jaguar Health (JAGX) Operating Expenses (2016 - 2025)

Jaguar Health (JAGX) has disclosed Operating Expenses for 11 consecutive years, with $24.5 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses rose 109.81% to $24.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $57.4 million through Dec 2025, up 35.04% year-over-year, with the annual reading at $57.4 million for FY2025, 35.04% up from the prior year.
  • Operating Expenses for Q4 2025 was $24.5 million at Jaguar Health, up from $10.3 million in the prior quarter.
  • The five-year high for Operating Expenses was $24.5 million in Q4 2025, with the low at $9.4 million in Q2 2022.
  • Average Operating Expenses over 5 years is $11.8 million, with a median of $10.9 million recorded in 2023.
  • The sharpest move saw Operating Expenses fell 26.01% in 2022, then surged 109.81% in 2025.
  • Over 5 years, Operating Expenses stood at $12.9 million in 2021, then dropped by 26.01% to $9.5 million in 2022, then increased by 3.26% to $9.9 million in 2023, then increased by 18.35% to $11.7 million in 2024, then soared by 109.81% to $24.5 million in 2025.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $24.5 million, $10.3 million, and $11.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.